Maternal antiepileptic drug use and effects on fetal development

Current Opinion in Pediatrics

Volumn 13, Issue 6, 2001, Pages 566-571

  Stoler, J M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; FELBAMATE; GABAPENTIN; GABATRIL; LAMOTRIGINE; NEUROTIN; PHENOBARBITAL; PHENYTOIN; TIAGABINE; VALPROATE SEMISODIUM; VIGABATRIN; ZONEGRAM; ZONISAMIDE;

BRADYCARDIA; CLEFT PALATE; CONGENITAL MALFORMATION; DOSE RESPONSE; EPILEPSY; FACE MALFORMATION; FETUS DEVELOPMENT; GENETIC SUSCEPTIBILITY; HUMAN; MATERNAL DISEASE; MENTAL DEFICIENCY; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SMALL FOR DATE INFANT; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTICONVULSANTS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0035668806     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200112000-00013     Document Type: Review

References (32)

1. Quality of life, epilepsy advances and the evolving role of anticonvulsants in women with epilepsy
2. Pregnancies of women with epilepsy: A population-based study in Iceland
3. Emergency trends in the treatment of rapid cycling bipolar disorder: A selected review
4. Non-seizure uses for the newer anti-epileptic drugs
5. Gabapentin for treatment of pain and tremor: A large case series
6. The teratogenicity of anticonvulsant drugs
7. Diagnosis of intracranial hemorrhage in utero after a maternal seizure
8. Experimental and clinical chemoteratogenesis
9. Prevalence and Etiology of Birth Defects
10. Malformations in offspring of women with epilepsy: A prospective study
11. Anticonvulsant teratogenesis: I. A study design for newborn infants
12. Birth outcomes in women exposed to anticonvulsant drugs
13. Congenital malformations due to antiepileptic drugs
14. Pregnancy in women with epilepsy
15. Digit effects produced by prenatal exposure to antiepileptic drugs
16. Spina bifida in infants of women treated with carbamazepine during pregnancy
17. The risk of spina bifida aperta after first trimester exposure to valproate in a prenatal cohort
18. Clinical manifestations of prenatal exposure to valproic acid using case reports and epidemiologic information
19. Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature
20. Birth weight in offspring of women with epilepsy
21. Epilepsy and pregnancy: Effect of antiepileptic drugs and lifestyle on birthweight
22. Intrauterine growth in the offspring of epileptic women: A prospective multicenter study
23. Body dimensions of infants exposed to antiepileptic drugs in utero: Observations spanning 25 years
24. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome
25. Fetal valproate syndrome: Is there a recognizable phenotype?
26. In utero exposure to phenobarbital and intelligence deficits in adult men
27. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age
28. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents
29. Antixodiant and GSH-related enzyme response to a single teratogenic exposure to the anticonvulsant phenytoin: Temporospatial evaluation
30. Phenytoin-induced cleft palate: Evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage
31. A mouse model for valproate teratogenicity: Parental effects, homeotic transformations and altered HOX expression
32. A North American registry for epilepsy and pregnancy, a unique public/private partnership of health surveillance